| pubmed-article:10351141 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10351141 | lifeskim:mentions | umls-concept:C1524059 | lld:lifeskim |
| pubmed-article:10351141 | lifeskim:mentions | umls-concept:C0031327 | lld:lifeskim |
| pubmed-article:10351141 | lifeskim:mentions | umls-concept:C0043117 | lld:lifeskim |
| pubmed-article:10351141 | lifeskim:mentions | umls-concept:C0085297 | lld:lifeskim |
| pubmed-article:10351141 | lifeskim:mentions | umls-concept:C0140430 | lld:lifeskim |
| pubmed-article:10351141 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:10351141 | pubmed:dateCreated | 1999-5-5 | lld:pubmed |
| pubmed-article:10351141 | pubmed:abstractText | Infusion of large amounts of intravenous immunoglobulin (IVIG) or anti-D can reverse the low platelet count in patients with ITP within hours of the initiation of treatment. In some cases, the effects of IVIG appear to far outlast several half-lives of the product. Several mechanisms have been proposed to explain these rapid and long term effects and these will be discussed in this review. | lld:pubmed |
| pubmed-article:10351141 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10351141 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10351141 | pubmed:citationSubset | T | lld:pubmed |
| pubmed-article:10351141 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10351141 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10351141 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10351141 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10351141 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10351141 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10351141 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10351141 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10351141 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:10351141 | pubmed:issn | 0955-3886 | lld:pubmed |
| pubmed-article:10351141 | pubmed:author | pubmed-author:FreedmanJJ | lld:pubmed |
| pubmed-article:10351141 | pubmed:author | pubmed-author:SempleJ WJW | lld:pubmed |
| pubmed-article:10351141 | pubmed:author | pubmed-author:LazarusA HAH | lld:pubmed |
| pubmed-article:10351141 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10351141 | pubmed:volume | 19 | lld:pubmed |
| pubmed-article:10351141 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10351141 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10351141 | pubmed:pagination | 289-94 | lld:pubmed |
| pubmed-article:10351141 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:10351141 | pubmed:meshHeading | pubmed-meshheading:10351141... | lld:pubmed |
| pubmed-article:10351141 | pubmed:meshHeading | pubmed-meshheading:10351141... | lld:pubmed |
| pubmed-article:10351141 | pubmed:meshHeading | pubmed-meshheading:10351141... | lld:pubmed |
| pubmed-article:10351141 | pubmed:meshHeading | pubmed-meshheading:10351141... | lld:pubmed |
| pubmed-article:10351141 | pubmed:meshHeading | pubmed-meshheading:10351141... | lld:pubmed |
| pubmed-article:10351141 | pubmed:meshHeading | pubmed-meshheading:10351141... | lld:pubmed |
| pubmed-article:10351141 | pubmed:meshHeading | pubmed-meshheading:10351141... | lld:pubmed |
| pubmed-article:10351141 | pubmed:meshHeading | pubmed-meshheading:10351141... | lld:pubmed |
| pubmed-article:10351141 | pubmed:meshHeading | pubmed-meshheading:10351141... | lld:pubmed |
| pubmed-article:10351141 | pubmed:meshHeading | pubmed-meshheading:10351141... | lld:pubmed |
| pubmed-article:10351141 | pubmed:meshHeading | pubmed-meshheading:10351141... | lld:pubmed |
| pubmed-article:10351141 | pubmed:meshHeading | pubmed-meshheading:10351141... | lld:pubmed |
| pubmed-article:10351141 | pubmed:meshHeading | pubmed-meshheading:10351141... | lld:pubmed |
| pubmed-article:10351141 | pubmed:meshHeading | pubmed-meshheading:10351141... | lld:pubmed |
| pubmed-article:10351141 | pubmed:year | 1998 | lld:pubmed |
| pubmed-article:10351141 | pubmed:articleTitle | Intravenous immunoglobulin and anti-D in idiopathic thrombocytopenic purpura (ITP): mechanisms of action. | lld:pubmed |
| pubmed-article:10351141 | pubmed:affiliation | Canadian Blood Services, Toronto Centre, ON, Canada. | lld:pubmed |
| pubmed-article:10351141 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10351141 | pubmed:publicationType | Review | lld:pubmed |
| pubmed-article:10351141 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10351141 | lld:pubmed |
